Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marina Concli Leite has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Health and Environmental Impacts of Major Foods Consumed in Regional Food Systems of Brazil

    by Marhya Júlia Silva Leite, Lucas de Almeida Moura, Eduardo De Carli, Dirce Maria Lobo Marchioni, Olivier Jolliet, Eliseu Verly, Aline Martins de Carvalho

    This study examines the relationship between the 1141 most consumed foods in Brazil and their individual and combined health and environmental impacts. Foods are analyzed across different food system clusters, based on the health burden (DALYs) in minutes of healthy life using the Health Nutritional Index (HENI), greenhouse gas emissions, and water use. The most consumed foods were in natura products, such as rice, beans and meat, and a few ultra-processed products such as biscuits and soft drinks. Our results revealed an average HENI of −5.89 min, with values varying from −39.69 min of healthy life (stuffed cookies) to 17.22 min (freshwater fish). Animal-derived products, particularly red meat, had the highest environmental costs, contributing significantly to greenhouse gas emissions and water use. In contrast, plant-based foods like beans and fruits had better HENI scores and lower environmental impacts. We also found that greenhouse gas emissions reached up to 21.3 kg CO2eq (beef dish), and water use peaked at 306.1 L (mozzarella pizza). Our findings provide valuable insights into the real-world consequences of individual and institutional food choices, demonstrating their measurable impacts on health and the environment. By moving beyond theoretical assumptions, this evidence strengthens the case for integrating sustainability into public food policies, including dietary guidelines that consider regional specificities and environmental concerns alongside nutritional recommendations.


  • Open Access

    How S100B crosses brain barriers and why it is considered a peripheral marker of brain injury

    by Vitor Gayger-Dias, Adriana Fk Vizuete, Letícia Rodrigues, Krista Minéia Wartchow, Larissa Bobermin, Marina Concli Leite, André Quincozes-Santos, Andrea Kleindienst, Carlos-Alberto Gonçalves

    S100B is a 21-kDa protein that is produced and secreted by astrocytes and widely used as a marker of brain injury in clinical and experimental studies. The majority of these studies are based on measurements in blood serum, assuming an associated increase in cerebrospinal fluid and a rupture of the blood–brain barrier (BBB). Moreover, extracerebral sources of S100B are often underestimated. Herein, we will review these interpretations and discuss the routes by which S100B, produced by astrocytes, reaches the circulatory system. We discuss the concept of S100B as an alarmin and its dual activity as an inflammatory and neurotrophic molecule. Furthermore, we emphasize the lack of data supporting the idea that S100B acts as a marker of BBB rupture, and the need to include the glymphatic system in the interpretations of serum changes of S100B. The review is also dedicated to valorizing extracerebral sources of S100B, particularly adipocytes. Furthermore, S100B per se may have direct and indirect modulating roles in brain barriers: on the tight junctions that regulate paracellular transport; on the expression of its receptor, RAGE, which is involved in transcellular protein transport; and on aquaporin-4, a key protein in the glymphatic system that is responsible for the clearance of extracellular proteins from the central nervous system. We hope that the data on S100B, discussed here, will be useful and that it will translate into further health benefits in medical practice.


  • Open Access

    Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B

    by Cristiane Batassini, Núbia Broetto, Lucas Silva Tortorelli, Milene Borsoi, Caroline Zanotto, Fabiana Galland, Tadeu Mello Souza, Marina Concli Leite, Carlos-Alberto Gonçalves

    Both glial fibrillary acidic protein (GFAP) and S100B have been used as markers of astroglial plasticity, particularly in brain injury; however, they do not necessarily change in the same time frame or direction. Herein, we induced a Parkinson’s disease (PD) model via a 6-OHDA intrastriatal injection in rats and investigated the changes in GFAP and S100B using ELISA in the substantia nigra (SN), striatum, and cerebrospinal fluid on the 1st, 7th, and 21st days following the injection. The model was validated using measurements of rotational behaviour induced by methylphenidate and tyrosine hydroxylase in the dopaminergic pathway. To our knowledge, this is the first measurement of cerebrospinal fluid S100B and GFAP in the 6-OHDA model of PD. Gliosis (based on a GFAP increase) was identified in the striatum, but not in the SN. We identified a transitory increment of cerebrospinal fluid S100B and GFAP on the 1st and 7th days, respectively. This initial change in cerebrospinal fluid S100B was apparently related to the mechanical lesion. However, the 6-OHDA-induced S100B secretion was confirmed in astrocyte cultures. Current data reinforce the idea that glial changes precede neuronal damage in PD; however, these findings also indicate that caution is necessary regarding the interpretation of data in this PD model.


  • Open Access

    Caloric restriction increases hippocampal glutamate uptake and glutamine synthetase activity in Wistar rats

    by Letícia Carina Ribeiro, André Quincozes-Santos, Marina Concli Leite, Renata Torres Abib, Juliana Kleinkauf-Rocha, Regina Biasibetti, Liane Nanci Rotta, Susana T. Wofchuk, Marcos Luiz Santos Perry, Carlos-Alberto Gonçalves, et al.


  • Developmental changes in content of glial marker proteins in rats exposed to protein malnutrition

    by Ana Maria Feoli, Marina C. Leite, Ana Carolina Tramontina, Francine Tramontina, Thais Posser, Letícia Rodrigues, Alessandra Swarowsky, André Quincozes-Santos, Rodrigo B. Leal, Carmem Gottfried, et al.


  • Ammonia-induced alteration in S100B secretion in astrocytes is not reverted by creatine addition

    by Marina Concli Leite, Giovana Brolese, Lucia Maria Vieira de Almeida, Cristopher Celintano Piñero, Carmem Gottfried, Carlos-Alberto Gonçalves


  • Transitory gliosis in the CA3 hippocampal region in rats fed on a ketogenic diet

    by M. C. Silva, J. Rocha, C. S. Pires, L. C. Ribeiro, G. Brolese, M. C. Leite, L. M. V. Almeida, F. Tramontina, D. R. Ziegler, C. A. Gonçalves

    The ketogenic diet (KD) is a high-fat, low-protein and low-carbohydrate diet included as medical practice against seizure disorders, particularly in children refractory to conventional anti-epileptic drug treatment. However, the molecular basis of its therapeutic effect remains unclear. Considering the growing evidence for the importance of glial cells for neuronal development, survival and plasticity, we investigated astrocyte protein markers from KD fed rats, in different regions of hippocampus, a brain structure commonly involved in seizure disorders. We found a transitory increment in GFAP in the CA3 hippocampal region, but not in the CA1 or dentate gyrus (DG). This change was not accompanied by changes in S100B content or glutamine synthetase activity. In order to evaluate possible hippocampal involvement we investigated spatial-cognitive behavior using the water-maze task. No changes were observed. This transitory gliosis in CA3 could be related to, or precede, other associated changes proposed to be involved in the attenuation of seizure disorders. These data reinforce the importance of hippocampal astrocytes as cell targets during KD feeding.


  • Ketogenic diet fed rats have low levels of S100B in cerebrospinal fluid

    by Denize R. Ziegler, Diogo L. Oliveira, Caroline Pires, Letícia Ribeiro, Marina Leite, Andreas Mendez, Daniela Gonçalves, Francine Tramontina, Luis V. Portela, Susana T. Wofchuk, et al.


  • β-Hydroxy-butyrate alters the extracellular content of S100B in astrocyte cultures

    by Marina Leite, Juliana K. Frizzo, Patrícia Nardin, Lúcia Maria Vieira de Almeida, Francine Tramontina, Carmem Gottfried, Carlos-Alberto Gonçalves